US EditionCovid-19: Fiocruz RNA vaccine has efficacy in animal testing
Summary by EBC
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Covid-19: Fiocruz RNA vaccine has efficacy in animal testing
The vaccine against covid-19 with RNA technology messenger, which is being developed by the Oswaldo Cruz Foundation (Fiocruz), presented excellent efficacy in animal testing. The results were similar to those demonstrated by mRNA vaccines already available on the market, such as the Pfizer and Modern, according to the coordinator of the Regional Development and Production Hub of RNA, the Institute of Technology in Immunobiological - Bio-Manguinh…
·Quadra, Brazil
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
